Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

E-ISSN： 1873-5592|7|11|1513-1529

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.11, 2006-11, pp. : 1513-1529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5574-5593

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Microglia - A Therapeutic Target in Neurological Diseases and Disorders)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-09 ,pp. : 719-719

Bentham Science Publishers

Access to resources Recommend Favorite

Catalpol: A Potential Therapeutic for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-04 ,pp. : 1278-1291

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Erythropoietin in Neurological Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Davunetide: Peptide Therapeutic in Neurological Disorders

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2591-2598

Bentham Science Publishers

Access to resources Recommend Favorite